VanEck Gold Miners ETF vs Eli Lilly And Co — how do they compare? VanEck Gold Miners ETF trades at $72.03, while Eli Lilly And Co trades at $1,175.8 (market cap $1.03T). The key difference: Eli Lilly And Co pays a 0.6% dividend while VanEck Gold Miners ETF pays none. Which is the better fit depends on your goals.
| GDX | LLY | |
|---|---|---|
52-Week High | $115.84 | $1.24K |
52-Week Low | $51.15 | $625.65 |
Market Cap | — | $1.03T |
Sector | — | Health |
Enterprise Value | — | $1.07T |
Dividend Yield | — | 0.6% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LLY trades at $1,154.27, down 2.6% today, amid a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q1 2026 EPS of $8.55 surpassing the $6.97 forecast. Revenue surged to $65.18B in 2025, driving a net income margin of 34.99%. Recent news includes the acquisition of AtaiBeckley for $2.8 billion, expanding its neuroscience pipeline.
Outlook remains positive with a consensus price target of $1,380, though high valuation multiples (P/E 41.09) and competitive pressures in obesity drugs present risks. Analyst sentiment is strongly bullish (73% buy ratings), supporting further upside if execution continues.
Trailing returns across standard periods
Latest headlines on both assets
The fund normally invests at least 80% of its total assets in common stocks and depositary receipts of companies involved in the gold mining industry. The index is a modified market-capitalization weighted index primarily comprised of publicly traded companies involved in the mining for gold and silver. The fund is non-diversified.
Read more on GDX →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →